首页> 外文期刊>Hong Kong medical journal = >Difficulties getting published in high-impact journals. Response from Editor in Chief
【24h】

Difficulties getting published in high-impact journals. Response from Editor in Chief

机译:困难在高影响力的期刊上发表。总编辑的回应

获取原文
       

摘要

To the Editor—We appreciate the Hong Kong Medical Journal (HKMJ)’s efforts to emphasise transparency and responsiveness, in the form of editorials, letters, and other correspondence during and after publication. Our research team has faced various difficulties submitting articles and getting published. Owing to the novelty and impact of our research and the compatibility with the journal, we hoped to submit to one of the most prestigious medical journals in our field. However, the author guidelines of our target journal indicate that original research articles are usually not considered for publication, and the majority of published articles are solicited reviews. Those guidelines also indicate that unsolicited editorials and short commentaries may be considered for publication. In contrast, HKMJ accepts a variety of article types with a focus on improving care of patients. This approach is also adopted by many other journals; for example, in his first Editorial as Editor-in-Chief of Circulation, Hill 1 said, “rather, we will focus on the impact of an article on advancing clinical practice”.
机译:致编辑-我们赞赏《香港医学日报》在出版期间和出版后以社论,信函和其他信函的形式强调透明度和响应能力的努力。我们的研究团队在提​​交文章和发表论文时遇到了各种困难。由于我们研究的新颖性和影响力以及与该期刊的兼容性,我们希望提交本领域最负盛名的医学期刊之一。但是,我们目标期刊的作者指南指出,通常不考虑发表原始研究文章,并且大多数已发表文章都是经过征集的。这些准则还表明,可以考虑发表未经请求的社论和简短评论。相比之下,HKMJ接受多种类型的文章,以改善患者的护理为重点。许多其他期刊也采用这种方法。例如,希尔1在他的第一本《循环》主编的社论中说:“相反,我们将专注于文章对推进临床实践的影响”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号